John Newman
Stock Analyst at Canaccord Genuity
(3.63)
# 2,182
Out of 4,693 analysts
928
Total ratings
45.6%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACET Adicet Bio | Maintained: Buy | $18 | $9.26 | +94.38% | 31 | Sep 2, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 | $2.31 | +203.03% | 15 | Sep 1, 2026 | |
| KZIA Kazia Therapeutics | Maintained: Buy | $29 | $12.63 | +129.61% | 2 | Aug 31, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $142 → $136 | $101.95 | +33.41% | 26 | Aug 31, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $25.30 | +97.63% | 14 | Aug 25, 2026 | |
| INCY Incyte | Initiated Coverage: Buy | $152 | $125.01 | +21.59% | 1 | Aug 21, 2026 | |
| MRKR Marker Therapeutics | Maintained: Buy | $8 | $1.30 | +515.38% | 15 | Aug 17, 2026 | |
| ATRA Atara Biotherapeutics | Maintained: Buy | $13 | $9.02 | +44.12% | 91 | Aug 13, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $14 | $1.99 | +605.29% | 38 | Aug 13, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $25 | $12.85 | +94.55% | 13 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $22.35 | +105.82% | 11 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.82 | +160.77% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $16.40 | +28.05% | 30 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.08 | +733.33% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $5.18 | +324.71% | 69 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $18.49 | +56.84% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $27.91 | +36.15% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $875 | $823.82 | +6.21% | 118 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.84 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.83 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $300 | $11.54 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $9.30 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $44 | $34.21 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.0013 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $352.77 | $19.01 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $25.07 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $11.91 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.7527 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13.86 | $9.45 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.49 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $6 | $1.72 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $60.00 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $16.05 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $17.93 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $14.58 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $0.7702 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.30 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $12.06 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $5.35 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $30.53 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.73 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $34.36 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $933.44 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $6 | $1.18 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $243.71 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $8.05 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $16.23 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $216.04 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.98 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $73.37 | n/a | 1 | Jun 10, 2009 |
Adicet Bio
Sep 2, 2026
Maintained: Buy
Price Target: $18
Current: $9.26
Upside: +94.38%
Compass Therapeutics
Sep 1, 2026
Maintained: Buy
Price Target: $7
Current: $2.31
Upside: +203.03%
Kazia Therapeutics
Aug 31, 2026
Maintained: Buy
Price Target: $29
Current: $12.63
Upside: +129.61%
BioNTech SE
Aug 31, 2026
Maintained: Buy
Price Target: $142 → $136
Current: $101.95
Upside: +33.41%
Tyra Biosciences
Aug 25, 2026
Maintained: Buy
Price Target: $50
Current: $25.30
Upside: +97.63%
Incyte
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $152
Current: $125.01
Upside: +21.59%
Marker Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $8
Current: $1.30
Upside: +515.38%
Atara Biotherapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $13
Current: $9.02
Upside: +44.12%
Allogene Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $14
Current: $1.99
Upside: +605.29%
Candel Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $25
Current: $12.85
Upside: +94.55%
Aug 12, 2026
Maintained: Buy
Price Target: $46
Current: $22.35
Upside: +105.82%
Aug 12, 2026
Reiterated: Buy
Price Target: $23
Current: $8.82
Upside: +160.77%
Aug 11, 2026
Maintained: Buy
Price Target: $21
Current: $16.40
Upside: +28.05%
Aug 6, 2026
Maintained: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
Aug 6, 2026
Maintained: Buy
Price Target: $22
Current: $5.18
Upside: +324.71%
Aug 6, 2026
Maintained: Buy
Price Target: $29
Current: $18.49
Upside: +56.84%
Aug 5, 2026
Maintained: Buy
Price Target: $38
Current: $27.91
Upside: +36.15%
Jul 22, 2026
Maintained: Buy
Price Target: $875
Current: $823.82
Upside: +6.21%
Nov 12, 2024
Maintained: Buy
Price Target: $5
Current: $0.84
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10
Current: $3.83
Upside: n/a
Oct 1, 2024
Maintained: Buy
Price Target: $6 → $300
Current: $11.54
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $43
Current: $9.30
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $52 → $44
Current: $34.21
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7 → $3
Current: $0.0013
Upside: n/a
May 26, 2021
Maintained: Buy
Price Target: $352.77
Current: $19.01
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $31
Current: $25.07
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $45
Current: $11.91
Upside: n/a
Mar 25, 2021
Maintained: Buy
Price Target: $5
Current: $0.7527
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: $13.86
Current: $9.45
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $1.49
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $31 → $6
Current: $1.72
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $60.00
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $16.05
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $17.93
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $14.58
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $0.7702
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.30
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $12.06
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $5.35
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $30.53
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $3.73
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $34.36
Upside: n/a
Mar 31, 2016
Maintained: Buy
Price Target: $18
Current: $933.44
Upside: n/a
Mar 9, 2015
Maintained: Hold
Price Target: $8 → $6
Current: $1.18
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $243.71
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $8.05
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $16.23
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $216.04
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.98
Upside: n/a
Jun 10, 2009
Maintained: Sell
Price Target: n/a
Current: $73.37
Upside: n/a